Media

NCPE recommends Omeprazole Appizped for reimbursement eligibility.

NCPE recommends Vabysmo for neovascular (wet) age-related macular degeneration treatment.

J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.

Sanofi, Gilead sign License Agreement with Kymera for protein degrader programs.

Stryker FDA-cleared InCompass Ankle; protein degrader partnerships drive innovation.

Hereditary angioedema therapy by CSL Behring gains positive nod in Germany.

FDA import ban issued on Olympus medical devices from Japan for quality violations.

New partnership advances reimbursement strategy for private practices.

Medicare exoskeleton coverage approved for ReWalk Personal Exoskeleton, sets key precedent.

Vor Bio, RemeGen sign Global License Agreement for RC98 development.